JCI - CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders

Go to JCI Insight

About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact

Clinical Research and Public Health
Current issue
Past issues
By specialty
Videos
- Conversations with Giants in Medicine
- Video Abstracts
Reviews
Viewpoint
Collections

CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders

Xiuying Bai, … , David Goltzman, Andrew C. Karaplis

Xiuying Bai, … , David Goltzman, Andrew C. Karaplis

Published April 15, 2025
Citation Information: J Clin Invest. 2025;135(8):e193400. https://doi.org/10.1172/JCI193400.

View: Text | PDF | Amended Article

CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders

Text
PDF

Abstract

Authors

Xiuying Bai, Dengshun Miao, Sophia Xiao, Dinghong Qiu, René St-Arnaud, Martin Petkovich, Ajay Gupta, David Goltzman, Andrew C. Karaplis

×

Full Text PDF

Download PDF (2.31 MB) | Download high-resolution PDF (8.95 MB)

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts